Grand Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SHSC:512 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
28 Jun 24	BuyHK$234,000	Weikun Tang	Individual	50,000	HK$4.68
20 Jun 24	BuyHK$525,800	Weikun Tang	Individual	110,000	HK$4.78
06 Jun 24	BuyHK$200,600	Chao Zhou	Individual	42,500	HK$4.72
24 May 24	BuyHK$270,480	Weikun Tang	Individual	56,000	HK$4.83
10 May 24	BuyHK$249,975	Chao Zhou	Individual	49,500	HK$5.05
09 May 24	BuyHK$488,700	Weikun Tang	Individual	100,000	HK$4.89
19 Apr 24	BuyHK$371,450	Weikun Tang	Individual	95,000	HK$3.91
08 Apr 24	BuyHK$399,455	Chao Zhou	Individual	101,000	HK$3.96
03 Apr 24	BuyHK$242,760	Weikun Tang	Individual	60,000	HK$4.05
26 Mar 24	BuyHK$407,400	Weikun Tang	Individual	100,000	HK$4.07
22 Mar 24	BuyHK$200,475	Chao Zhou	Individual	49,500	HK$4.05
21 Mar 24	BuyHK$227,695	Chao Zhou	Individual	56,500	HK$4.03
20 Mar 24	BuyHK$381,470	Weikun Tang	Individual	100,000	HK$3.81

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 512?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	286,039,153	8.17%
Institutions	352,444,815	10.1%
VC/PE Firms	356,648,142	10.2%
General Public	791,647,889	22.6%
Individual Insiders	1,715,029,649	49%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 77.27% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
48.9%	Hu Kaijun	1,713,191,149	HK$8.2b	0%	no data
10.2%	CDH Investment Management Company Limited	356,648,142	HK$1.7b	0%	22.42%
8.17%	China Grand Enterprises Incorporation	286,039,153	HK$1.4b	0%	no data
2.84%	GL Capital Group	99,438,959	HK$477.3m	0%	38.25%
2.28%	Lion River I N.V.	79,735,000	HK$382.7m	0%	52.54%
1.52%	The Vanguard Group, Inc.	53,164,181	HK$255.2m	0.55%	no data
0.76%	Dimensional Fund Advisors LP	26,664,113	HK$128.0m	-0.73%	no data
0.73%	Bosera Asset Management Co., Ltd.	25,533,500	HK$122.6m	0%	0.07%
0.62%	GF Fund Management Co., Ltd.	21,842,000	HK$104.8m	0%	0.03%
0.59%	BlackRock, Inc.	20,755,027	HK$99.6m	0.81%	no data
0.12%	E Fund Management Co., Ltd.	4,100,000	HK$19.7m	0%	no data
0.11%	Principal Global Investors, LLC	3,940,500	HK$18.9m	-27.2%	no data
0.099%	State Street Global Advisors, Inc.	3,452,660	HK$16.6m	8.03%	no data
0.091%	American Century Investment Management Inc	3,185,038	HK$15.3m	14.6%	no data
0.031%	PGIM, Inc.	1,092,500	HK$5.2m	0%	no data
0.027%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	958,500	HK$4.6m	0%	no data
0.025%	China Southern Asset Management Co., Ltd.	877,500	HK$4.2m	0%	no data
0.024%	Penghua Fund Management Co., Ltd.	845,000	HK$4.1m	0%	no data
0.024%	Charles Schwab Investment Management, Inc.	842,847	HK$4.0m	-0.51%	no data
0.021%	Weikun Tang	731,000	HK$3.5m	0%	no data
0.02%	Geode Capital Management, LLC	685,520	HK$3.3m	-0.74%	no data
0.017%	Eaton Vance Management	608,500	HK$2.9m	0%	no data
0.017%	Chit Lam	579,000	HK$2.8m	0%	no data
0.014%	Yinhua Fund Management Co., Ltd.	501,500	HK$2.4m	0%	no data
0.014%	Ping An UOB Fund Management Co., Ltd.	490,500	HK$2.4m	0%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/31 21:04
End of Day Share Price	2024/12/31 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Grand Pharmaceutical Group Limited is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yanyin Zhu	China International Capital Corporation Limited
Xiao Wei Lin	Everbright Securities Co. Ltd.
Yiling Chen	Guosen Securities Co., Ltd.